242 related articles for article (PubMed ID: 1834848)
1. Amlodipine: an effective once-daily antihypertensive agent.
Tyler HM
J Hum Hypertens; 1991 Aug; 5 Suppl 1():61-6. PubMed ID: 1834848
[TBL] [Abstract][Full Text] [Related]
2. Amlodipine in the treatment of hypertension.
Kaplan NM
Postgrad Med J; 1991; 67 Suppl 5():S15-9. PubMed ID: 1839432
[TBL] [Abstract][Full Text] [Related]
3. Amlodipine in hypertension: an overview of the clinical dossier.
Julius S
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S27-33. PubMed ID: 2467123
[TBL] [Abstract][Full Text] [Related]
4. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
[TBL] [Abstract][Full Text] [Related]
6. Amlodipine and captopril in moderate-severe essential hypertension.
Maclean D; Mitchell ET; Wilcox RG; Walker P; Tyler HM
J Hum Hypertens; 1988 Aug; 2(2):127-32. PubMed ID: 2977406
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, parallel, comparative evaluation of amlodipine against captopril in the monotherapeutic treatment of mild and moderate essential hypertension: interim results.
Velasco M; Hernández R; Urbina A; Hernández O; Guevara J
Postgrad Med J; 1991; 67 Suppl 5():S32-4. PubMed ID: 1839436
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness and tolerance of amlodipine in treatment of patients with mild to moderate hypertension. Results of a long-term study with a new calcium antagonist].
Habeler G; Lenzhofer R; Pall H; Tomaschek A; Ziebart-Schroth A; Zirm B; Ganzinger U
Wien Klin Wochenschr; 1992; 104(1):16-20. PubMed ID: 1532108
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
10. [Safety and antihypertensive efficacy of the dihydropyridine calcium antagonist Amlodipine besylate--results from an observational study in 9,672 patients].
Keck M; Sauerbrey-Wullkopf N; Regourd E; Clemens A
MMW Fortschr Med; 2004 Dec; 146(Suppl 3-4):115-21. PubMed ID: 15662901
[TBL] [Abstract][Full Text] [Related]
11. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of mild to moderate hypertension. Efficacy and tolerance of Amlodipine in comparison with the combination nifedipine/mefruside].
Höfling B; Häringer E; Herrmann W; Pieske H; Pieske R; Philippi M
Fortschr Med; 1991 May; 109(15):327-30. PubMed ID: 1830287
[TBL] [Abstract][Full Text] [Related]
13. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.
Brachmann J; Ansari A; Mahla G; Handrock R; Klebs S
Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097
[TBL] [Abstract][Full Text] [Related]
14. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
15. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
Ferri C; Croce G; Desideri G
Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of amlodipine, a new long-acting calcium antagonist, in mild and moderate hypertension.
Escudero J; Hernandez H
Int J Clin Pharmacol Res; 1991; 11(5):243-6. PubMed ID: 1839989
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
19. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
20. Amlodipine: a double-blind evaluation of the dose-response relationship in mild to moderate hypertension.
Frick MH; McGibney D; Tyler HM
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S76-8. PubMed ID: 2467135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
